Within the scope of research and development activities aimed at developing cellular and gene therapy products for use in the treatment and prevention of diseases by closely following scientific developments, products developed as a result of studies on developing stem cells, cellular products, tissue products, extracellular vesicles and immunotherapeutic products from different tissue sources are included.

By closely following the technological developments in the world and using current technologies such as three-dimensional bioprinters and new generation tissue engineering technologies, the products to be developed within the scope of biomaterial research and development activities with biocompatible, biodegradable properties will be products for bone and cartilage damage, tissue and organ damage, and wound and burn treatment. It includes products developed as a result of development studies. 

It includes products developed as a result of research and development studies aimed at formulating functional foods and food supplements specific to many different diseases, especially neurological and neurodegenerative diseases (such as autism spectrum disorder, cerebral palsy, dementia), by taking a holistic approach in the treatment and prevention of diseases.

Since we believe that laboratory evaluations are important and a priority in the treatment and prevention of diseases, we closely follow current scientific developments and include products developed as a result of many different disease-specific test panels within the scope of research and development activities aimed at developing biochemical, metabolic and genetic test panels.